Double Trouble—COVID-19 and the Widespread Use of Corticosteroids: Are We Staring at an Osteonecrosis Epidemic?

BACKGROUND: A combination of immune-mediated vascular damage and routine use of systemic corticosteroid (CS) therapy in COVID-19 may significantly increase the risk and burden of osteonecrosis (ON) after COVID-19. This narrative review explores the pathogenesis, risk factors, and possible preventive...

Descripción completa

Detalles Bibliográficos
Autor principal: Shetty, Gautam M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547122/
https://www.ncbi.nlm.nih.gov/pubmed/34720174
http://dx.doi.org/10.1007/s43465-021-00546-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547122/
https://www.ncbi.nlm.nih.gov/pubmed/34720174
http://dx.doi.org/10.1007/s43465-021-00546-8

Ejemplares similares